Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: A cohort study

Climacteric

Volumn 5, Issue 2, 2002, Pages 151-155

  Dew, J E ^a   Wren, B G ^a   Eden, J A ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Breast cancer; Estrogen receptors; Hormone replacement therapy; Tamoxifen

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE SULFATE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PROGESTERONE; TAMOXIFEN; GESTAGEN; PROGESTERONE RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; FEMALE; HISTOPATHOLOGY; HORMONE RECEPTOR INTERACTION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECURRENCE RISK; REGRESSION ANALYSIS; AUSTRALIA; BREAST TUMOR; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; ESTROGEN THERAPY; INTRADERMAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MORTALITY; NEOPLASM; ORAL DRUG ADMINISTRATION; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; NEW SOUTH WALES; PROGESTINS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 0036001333     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.5.2.151.155     Document Type: Article

References (15)

1. Tamoxifen for early breast cancer: An overview of the randomised trials
2. The prevalence of menopausal symptoms in women treated for breast cancer
3. Gynaecological complications of women treated with tamoxifen for breast cancer
4. Estrogen replacement therapy in breast cancer survivors
5. Endocrine management of advanced breast cancer
6. Steroid hormones in endometrial and breast cancer
7. Hormone replacement therapy after breast cancer
8. The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study
9. Hormones and breast cell proliferation
10. Hormone receptors and breast cancer
11. Hormone replacement therapy for breast cancer survivors: Fact versus fears
12. Progestins both stimulate and inhibit breast cancer cell cycle progression whilst increasing expression of transforming growth factor-α, epidermal growth factor receptor, c-fos, c-myc genes
13. Kip1
14. Effects of progestins for menopausal symptoms in women with a history of breast cancer
15. Estrogen levels in postmenopausal women with hot flushes